News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Catherine M. Dang, MD

Articles by Catherine M. Dang, MD

Local Recurrence Risk Factors in Women Treated With BCT for Early-Stage Breast Cancer

ByCatherine M. Dang, MD,Armando E. Giuliano, MD, FACS

September 14th 2011

The article by Revesz and Khan is an excellent summary of the state of our knowledge of margin width in relation to breast cancer recurrence.

Latest Updated Articles

Local Recurrence Risk Factors in Women Treated With BCT for Early-Stage Breast Cancer
September 14th 2011

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

Achieving a “Functional Cure” With Multiple Myeloma Therapy

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)